Hot Tea Consumption and Esophageal Cancer Risk: A Meta-Analysis of Observational Studies.

case-control study esophageal cancer hot tea meta-analysis risk

Journal

Frontiers in nutrition
ISSN: 2296-861X
Titre abrégé: Front Nutr
Pays: Switzerland
ID NLM: 101642264

Informations de publication

Date de publication:
2022
Historique:
received: 08 12 2021
accepted: 14 03 2022
entrez: 28 4 2022
pubmed: 29 4 2022
medline: 29 4 2022
Statut: epublish

Résumé

Many laboratory studies have shown that tea consumption protected against the development of esophageal cancer (EC). However, in epidemiological studies, inconsistent or even contradictory results were frequently observed, especially when drinking tea at higher temperatures. We conducted a meta-analysis based on published observational studies to explore whether hot tea consumption was a risk factor of EC. Relevant studies were searched in PubMed, Embase, and Web of science up to October 13, 2021, and we also manually retrieved the literature in the included studies and recent reviews. A total of 23 eligible reports were identified, including 5,050 cases and 10,609 controls, and a meta-analysis with Comprehensive Meta-Analysis (CMA) software (version 2.0) was conducted. A statistically significant increased EC risk was observed when drinking tea at higher temperature (odds ratios (ORs) = 1.79, 95% CI: 1.48-2.15, This meta-analysis showed that people who drank hot tea had a significantly increased risk of Esophageal squamous cell carcinoma (ESCC), but no significant association for EAC.

Identifiants

pubmed: 35479756
doi: 10.3389/fnut.2022.831567
pmc: PMC9035825
doi:

Types de publication

Systematic Review

Langues

eng

Pagination

831567

Informations de copyright

Copyright © 2022 Luo and Ge.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

J Assoc Physicians India. 2000 Aug;48(8):781-7
pubmed: 11273469
Asian Pac J Cancer Prev. 2014;15(20):8657-60
pubmed: 25374185
Biometrics. 1994 Dec;50(4):1088-101
pubmed: 7786990
BMC Cancer. 2018 Mar 1;18(1):236
pubmed: 29490609
Gastrointest Endosc. 2018 Sep;88(3):413-426
pubmed: 29709526
Cancer Causes Control. 2010 Sep;21(9):1475-84
pubmed: 20467799
Asian Pac J Cancer Prev. ;18(2):333-337
pubmed: 28345328
Nutr Cancer. 2013;65(1):1-16
pubmed: 23368908
Br J Cancer. 2000 Jul;83(1):127-32
pubmed: 10883680
Int J Cancer. 2005 Jan 20;113(3):456-63
pubmed: 15455378
Int J Cancer. 2009 Apr 15;124(8):1907-13
pubmed: 19123468
Am J Prev Med. 2015 Dec;49(6):952-60
pubmed: 26590941
Br J Cancer. 2001 Nov 30;85(11):1667-70
pubmed: 11742485
J Assoc Physicians India. 2009 Sep;57:631-5
pubmed: 20213999
Stat Med. 2002 Jun 15;21(11):1539-58
pubmed: 12111919
Clin Epidemiol. 2018 Sep 25;10:1307-1320
pubmed: 30310324
Gut. 2011 Aug;60(8):1029-37
pubmed: 21406386
J Natl Cancer Inst. 1994 Jun 1;86(11):855-8
pubmed: 8182766
Am J Clin Nutr. 2012 Nov;96(5):1056-63
pubmed: 23053557
Int J Cancer. 2000 Nov 15;88(4):658-64
pubmed: 11058886
CA Cancer J Clin. 2020 Jan;70(1):7-30
pubmed: 31912902
Oncol Rep. 2015 Jan;33(1):297-303
pubmed: 25333353
BMJ. 2009 Mar 26;338:b929
pubmed: 19325180
Asian Pac J Cancer Prev. 2014;15(6):2765-9
pubmed: 24761898
Int J Cancer. 2014 Sep 15;135(6):1470-9
pubmed: 24535727
BMC Cancer. 2015 Jun 02;15:449
pubmed: 26031666
Asia Pac J Clin Nutr. 1997 Jun;6(2):96-8
pubmed: 24394709
Int J Cancer. 2019 Jun 1;144(11):2669-2676
pubmed: 30496610
BMC Gastroenterol. 2012 Nov 21;12:165
pubmed: 23170950
BMJ. 1998 Feb 7;316(7129):469; author reply 470-1
pubmed: 9492685
Eur J Cancer. 2010 Jul;46(10):1873-81
pubmed: 20395127
Nat Clin Pract Gastroenterol Hepatol. 2008 Sep;5(9):517-26
pubmed: 18679388
Dis Esophagus. 2015 Jan;28(1):59-67
pubmed: 23795778
Medicine (Baltimore). 2017 Dec;96(50):e9325
pubmed: 29390400
Nutr Cancer. 2013;65(6):802-12
pubmed: 23909723
Br J Cancer. 1979 Mar;39(3):293-309
pubmed: 465299
Nutrition. 2009 Jul-Aug;25(7-8):753-61
pubmed: 19394796
Lancet Oncol. 2016 Jul;17(7):877-878
pubmed: 27318851
Hepatogastroenterology. 2002 Sep-Oct;49(47):1290-2
pubmed: 12239927
Front Oncol. 2022 Feb 23;12:852791
pubmed: 35280744
Asian Pac J Cancer Prev. 2013;14(9):5085-8
pubmed: 24175780
BMC Cancer. 2006 Dec 15;6:287
pubmed: 17173682
J Gastroenterol. 2019 Aug;54(8):669-673
pubmed: 31172291
Ann Intern Med. 2018 Apr 3;168(7):489-497
pubmed: 29404576
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Asian Pac J Cancer Prev. 2011;12(1):229-33
pubmed: 21517263
J Epidemiol. 1998 Oct;8(4):235-43
pubmed: 9816815
Ann Thorac Surg. 2019 May;107(5):1472-1479
pubmed: 30605641
World J Gastroenterol. 2012 Jan 14;18(2):126-35
pubmed: 22253518
Br J Cancer. 2001 Jan 5;84(1):120-1
pubmed: 11139325
Discov Oncol. 2022 Jan 3;13(1):1
pubmed: 35201482
BMJ. 2003 Sep 6;327(7414):557-60
pubmed: 12958120

Auteurs

Hui Luo (H)

Department of Radiation Oncology, The Affiliated Cancer Hospital of Zhengzhou University, Henan, China.

Hong Ge (H)

Department of Radiation Oncology, The Affiliated Cancer Hospital of Zhengzhou University, Henan, China.

Classifications MeSH